A Genetic Variant in pre-miR-27a Is Associated with a Reduced Renal Cell Cancer Risk in a Chinese Population

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Shi, Danni ^a,b   Li, Pu ^c   Ma, Lan ^a,b   Zhong, Dongyan ^a,b   Chu, Haiyan ^a,b   Yan, Fu ^b   Lv, Qiang ^c   Qin, Chao ^c   Wang, Wei ^b   Wang, Meilin ^a,b   Tong, Na ^a   Zhang, Zhengdong ^a,b   Yin, Changjun ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Medical University   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ADULT; AGE; ARTICLE; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRE MIR 27A GENE; RISK FACTOR; RISK REDUCTION; RNA GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

CARCINOMA, RENAL CELL; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION; RISK FACTORS;

EID: 84868126747     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046566     Document Type: Article

References (39)

1. Chow WH, Dong LM, Devesa SS, (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7: 245-257.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
3. Calle EE, Kaaks R, (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4: 579-591.
4. Setiawan VW, Stram DO, Nomura AM, Kolonel LN, Henderson BE, (2007) Risk factors for renal cell cancer: the multiethnic cohort. Am J Epidemiol 166: 932-940.
5. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA, (2000) The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 89: 630-639.
6. Lee Y, Jeon K, Lee JT, Kim S, Kim VN, (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21: 4663-4670.
7. Lee Y, Ahn C, Han J, Choi H, Kim J, et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419.
8. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U, (2004) Nuclear export of microRNA precursors. Science 303: 95-98.
9. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, et al. (2001) A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834-838.
10. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
11. Ambros V, (2003) MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113: 673-676.
12. Bartels CL, Tsongalis GJ, (2009) MicroRNAs: novel biomarkers for human cancer. Clin Chem 55: 623-631.
13. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
14. Duan R, Pak C, Jin P, (2007) Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 16: 1124-1131.
15. Hu Z, Chen J, Tian T, Zhou X, Gu H, et al. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118: 2600-2608.
16. Sun Q, Gu H, Zeng Y, Xia Y, Wang Y, et al. (2010) Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci 101: 2241-2247.
17. Yang R, Schlehe B, Hemminki K, Sutter C, Bugert P, et al. (2010) A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat 121: 693-702.
18. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S, (2007) The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 67: 11001-11011.
19. Lei Y, Geng Z, Guo-Jun W, He W, Jian-Lin Y, (2010) Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance. Mol Cell Biochem 344: 23-31.
20. Ficarra V, Martignoni G, Maffei N, Brunelli M, Novara G, et al. (2005) Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer 103: 68-75.
21. Harfe BD, (2005) MicroRNAs in vertebrate development. Curr Opin Genet Dev 15: 410-415.
22. Gao LB, Bai P, Pan XM, Jia J, Li LJ, et al. (2011) The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 125: 571-574.
23. Peng S, Kuang Z, Sheng C, Zhang Y, Xu H, et al. (2010) Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Dig Dis Sci 55: 2288-2293.
24. Zhu L, Chu H, Gu D, Ma L, Shi D, et al. (2012) A functional polymorphism in miRNA-196a2 is associated with colorectal cancer risk in a Chinese population. DNA Cell Biol 31: 350-354.
25. Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, et al. (2008) Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res 14: 7956-7962.
26. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, et al. (2008) Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 105: 7269-7274.
27. Zeng Y, Cullen BR, (2003) Sequence requirements for micro RNA processing and function in human cells. RNA 9: 112-123.
28. Zeng Y, Yi R, Cullen BR, (2005) Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J 24: 138-148.
29. Liu T, Tang H, Lang Y, Liu M, Li X, (2009) MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 273: 233-242.
30. Chintharlapalli S, Papineni S, Abdelrahim M, Abudayyeh A, Jutooru I, et al. (2009) Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells. Int J Cancer 125: 1965-1974.
31. Altieri DC, (2001) The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7: 542-547.
32. Baytekin F, Tuna B, Mungan U, Aslan G, Yorukoglu K, (2011) Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma. Urol Oncol 29: 502-507.
33. Zamparese R, Pannone G, Santoro A, Lo Muzio L, Corsi F, et al. (2008) Survivin expression in renal cell carcinoma. Cancer Invest 26: 929-935.
34. Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, et al. (2005) Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness. Clin Cancer Res 11: 5128-5139.
35. Steffens J, Bock R, Braedel HU, Isenberg E, Buhrle CP, et al. (1992) Renin-producing renal cell carcinomas-clinical and experimental investigations on a special form of renal hypertension. Urol Res 20: 111-115.
36. Maitland ML, Kasza KE, Karrison T, Moshier K, Sit L, et al. (2009) Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment. Clin Cancer Res 15: 6250-6257.
37. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, et al. (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166: 1871-1877.
38. McLaughlin JK, Lipworth L, (2000) Epidemiologic aspects of renal cell cancer. Semin Oncol 27: 115-123.
39. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P, (2005) Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer 114: 101-108.